M Aristides

735 total citations
29 papers, 588 citations indexed

About

M Aristides is a scholar working on Economics and Econometrics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, M Aristides has authored 29 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Economics and Econometrics, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in M Aristides's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Lung Cancer Treatments and Mutations (9 papers) and Colorectal Cancer Treatments and Studies (4 papers). M Aristides is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Lung Cancer Treatments and Mutations (9 papers) and Colorectal Cancer Treatments and Studies (4 papers). M Aristides collaborates with scholars based in United States, United Kingdom and Australia. M Aristides's co-authors include Joan H. Schiller, Nikos Maniadakis, C.D. Forbes, Linda Davies, M Drummond, Patrick Fitzgerald, Thierry Le Chevalier, Jan P. van Meerbeeck, Ronald B. Natale and P. Thomas and has published in prestigious journals such as Journal of Clinical Oncology, The American Journal of Cardiology and British journal of surgery.

In The Last Decade

M Aristides

25 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Aristides United States 11 271 232 103 80 67 29 588
Trine Lembrecht Jørgensen Denmark 12 156 0.6× 409 1.8× 89 0.9× 120 1.5× 59 0.9× 41 764
Ilaria Ardoino Italy 15 113 0.4× 173 0.7× 67 0.7× 168 2.1× 140 2.1× 43 699
C Proudlove United Kingdom 11 126 0.5× 99 0.4× 60 0.6× 60 0.8× 59 0.9× 15 466
I‐Chun Thomas United States 15 356 1.3× 94 0.4× 61 0.6× 107 1.3× 40 0.6× 39 644
Claire Siemes Netherlands 13 109 0.4× 250 1.1× 28 0.3× 169 2.1× 136 2.0× 21 869
Abdulaali R. Almutairi Saudi Arabia 11 82 0.3× 189 0.8× 45 0.4× 89 1.1× 126 1.9× 48 597
Marcelo Cerullo United States 18 160 0.6× 262 1.1× 173 1.7× 279 3.5× 106 1.6× 58 811
Lisa M. Meckley United States 14 217 0.8× 39 0.2× 198 1.9× 62 0.8× 57 0.9× 33 730
Luciano Frontini Italy 10 360 1.3× 615 2.7× 81 0.8× 87 1.1× 55 0.8× 16 943
James Chan United States 18 87 0.3× 139 0.6× 141 1.4× 71 0.9× 80 1.2× 29 947

Countries citing papers authored by M Aristides

Since Specialization
Citations

This map shows the geographic impact of M Aristides's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Aristides with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Aristides more than expected).

Fields of papers citing papers by M Aristides

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Aristides. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Aristides. The network helps show where M Aristides may publish in the future.

Co-authorship network of co-authors of M Aristides

This figure shows the co-authorship network connecting the top 25 collaborators of M Aristides. A scholar is included among the top collaborators of M Aristides based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Aristides. M Aristides is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Quinn, Casey, et al.. (2016). A Principal Component Analysis of Overall Survival Outcomes and List Prices of Oncology Drugs in Europe. Value in Health. 19(3). A147–A148.
2.
Aristides, M, et al.. (2005). Determining patient preferences for improved chemotoxicity during treatment for advanced bladder cancer. European Journal of Cancer Care. 14(2). 141–142. 3 indexed citations
3.
Chevalier, Thierry Le, Giorgio V. Scagliotti, Ronald B. Natale, et al.. (2004). Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes. Lung Cancer. 47(1). 69–80. 225 indexed citations
4.
5.
6.
7.
Schiller, Joan H., Dominic Tilden, M Aristides, et al.. (2003). Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in Europe. Lung Cancer. 43(1). 101–112. 35 indexed citations
8.
9.
Aristides, M, et al.. (2002). Economic Evaluation of Gemcitabine Alone and in Combination with Cisplatin in the Treatment of Nonsmall Cell Lung Cancer. PharmacoEconomics. 20(5). 325–337. 34 indexed citations
10.
11.
Davey, Peter, Narayan Rajan, Michael Lees, & M Aristides. (2001). Cost-Effectiveness of Pergolide Compared to Bromocriptine in the Treatment of Parkinson's Disease: A Decision-Analytic Model. Value in Health. 4(4). 308–315. 20 indexed citations
12.
Botwood, N., J McKendrick, M Aristides, et al.. (2001). Economic evaluation of Gemzar/cisplatin relative to other cisplatin based treatments for non small cell lung (NSCLC) cancer in the UK. European Journal of Cancer. 37. S233–S233. 1 indexed citations
13.
Botwood, N., J McKendrick, M Aristides, et al.. (2001). CN4: ECONOMIC EVALUATION OF GEMZAR/CISPLATIN RELATIVE TO OTHER CISPLATIN BASED TREATMENTS FOR NON SMALL CELL LUNG (NSCLC) CANCER IN THE UK. Value in Health. 4(2). 54–55. 1 indexed citations
14.
15.
Benrimoj, Shalom I., et al.. (2000). Economic Impact of Increased Clinical Intervention Rates in Community Pharmacy. PharmacoEconomics. 18(5). 459–468. 50 indexed citations
16.
Davey, Peter, et al.. (1998). Cost–effectiveness of vitamin E therapy in the treatment of patients with angiographically proven coronary narrowing (CHAOS trial). The American Journal of Cardiology. 82(4). 414–417. 19 indexed citations
17.
18.
Davey, Peter, et al.. (1997). Clinical outcomes with insulin lispro compared with human regular insulin: a meta-analysis. Clinical Therapeutics. 19(4). 656–674. 30 indexed citations
19.
Drummond, M, M Aristides, Linda Davies, & C.D. Forbes. (1994). Economic evaluation of standard heparin and enoxaparin for prophylaxis against deep vein thrombosis in elective hip surgery. British journal of surgery. 81(12). 1742–1746. 57 indexed citations
20.
Aristides, M & Alan Shiell. (1993). The effects on hospital use and costs of a domiciliary palliative care nursing service.. PubMed. 16(4). 405–13. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Trine Lembrecht Jørgensen Breakdown of academic impact, for papers by Ilaria Ardoino Breakdown of academic impact, for papers by C Proudlove Breakdown of academic impact, for papers by I‐Chun Thomas Breakdown of academic impact, for papers by Claire Siemes Breakdown of academic impact, for papers by Abdulaali R. Almutairi Breakdown of academic impact, for papers by Marcelo Cerullo Breakdown of academic impact, for papers by Lisa M. Meckley Breakdown of academic impact, for papers by Luciano Frontini Breakdown of academic impact, for papers by James Chan
Rankless by CCL
2026